Patents by Inventor Charles D. Swerdlow
Charles D. Swerdlow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140324123Abstract: Method and apparatus for diagnosis of conductor anomalies, such as partial conductor failures, in an implantable lead for an implantable medical device are disclosed. In various embodiments, small changes in the lead impedance are identified by the use of a small circuit element that is incorporated as part of the distal end of the implantable lead. In various embodiments, the small circuit element is electrically connected to a lead conductor and/or electrode of the implantable lead. Methods of diagnosing conductor anomalies in accordance with these embodiments generate measured values that depend only on the impedance of the conductors and electrodes of the lead, and not on the behavior of the conductor-tissue interface and other body tissues.Type: ApplicationFiled: March 25, 2014Publication date: October 30, 2014Inventors: Mark W. Kroll, Charles D. Swerdlow
-
Patent number: 8798750Abstract: In general, the disclosure describes techniques for detecting lead related conditions, such as lead fractures or other lead integrity issues. As described herein, delivering an electrical signal through selected electrodes may result in, reveal, or amplify noise if a lead related condition is present. A processor may detect electrical noise indicative of the lead related condition subsequent to the delivery of the electrical signal, and identify a lead related condition in response to detecting the noise.Type: GrantFiled: March 8, 2010Date of Patent: August 5, 2014Assignee: Medtronic, Inc.Inventors: Bruce D. Gunderson, Kevin A. Wanasek, Charles D. Swerdlow
-
Patent number: 8644923Abstract: A method and apparatus sense a cardiac electrical signal and determine a signal quality parameter of the cardiac electrical signal. A number of shock pulses to be delivered to a patient's heart is determined in response to the signal quality parameter. Each of the shock pulses are scheduled to be delivered at a unique offset from a T-wave shock interval in one embodiment of the invention.Type: GrantFiled: July 24, 2008Date of Patent: February 4, 2014Assignees: Medtronic, Inc., Imperception, Inc.Inventors: Paul A. Belk, Charles D. Swerdlow, Linda L. Ruetz
-
Patent number: 8565865Abstract: Methods for determination of timing for electrical shocks to the heart to determine shock strength necessary to defibrillate a fibrillating heart. The timing corresponds the window of most vulnerability in the heart, which occurs during the T-wave of a heartbeat. Using a derivatized T-wave representation, the timing of most vulnerability is determined by a center of the area method, peak amplitude method, width method, or other similar methods. Devices are similarly disclosed embodying the methods of the present disclosure.Type: GrantFiled: July 24, 2008Date of Patent: October 22, 2013Assignees: Medtronic, Inc., Imperception, Inc.Inventors: Paul A. Belk, Jian Cao, Jeffrey M. Gillberg, Charles D. Swerdlow
-
Patent number: 8401638Abstract: A method for determining a cardiac shock strength, for example the programmed first-therapeutic shock strength of an implantable cardioverter defibrillator (ICD), including the steps of sensing a change in a T-wave of an electrogram with respect to time such as the maximum of the first derivative of a T-wave of an electrogram; delivering a test shock by (i) delivering a test shock at a test-shock strength and at a test-shock time relating to the maximum of the first derivative of the T-wave with respect to time; and (ii) sensing for cardiac fibrillation. If fibrillation is not sensed, test-shock delivery is repeated at the same test-shock strength and at specific, different test-shock times relating to the maximum of the first derivative of the T-wave. If fibrillation is still not sensed, the shock strength is decreased and test shocks are repeated at the same specific test shock times relative to the maximum of the first derivative of the T-wave.Type: GrantFiled: August 21, 2007Date of Patent: March 19, 2013Assignee: Imperception, Inc.Inventors: Charles D. Swerdlow, Kalyanam Shivkumar
-
Publication number: 20120191153Abstract: Techniques for diagnosing lead fractures and lead connection problems are described. One or more medical leads may be coupled to an implantable medical device (IMD) to position electrodes or other sensors at different locations within a patient than the IMD. The IMD may include a lead diagnostic module configured to diagnose problems with a coupled lead and automatically select between a lead fracture problem and a lead connection problem based on the diagnosis. The diagnosis of either lead fracture problems or lead connection problems may be based on a timing of an increased impedance value with respect to connection of the lead to the IMD, a return to baseline impedance values after the increased impedance value, an abrupt rise of the increased impedance value, maximum impedance values, or oversensing. An external device may present the diagnosis to a user to facilitate appropriate corrective action.Type: ApplicationFiled: January 21, 2011Publication date: July 26, 2012Applicant: Medtronic, Inc.Inventors: Charles D. Swerdlow, Haresh G. Sachanandani, Bruce D. Gunderson
-
Patent number: 8064996Abstract: A method and apparatus for determining a T-wave shock interval sense a cardiac electrogram (EGM) signal comprising a T-wave signal. A T-wave center is determined from the EGM signal, and a T-wave shock interval is determined in response to determining the T-wave center. A T-wave shock is delivered at the T-wave shock interval computed based on the T-wave center.Type: GrantFiled: October 3, 2007Date of Patent: November 22, 2011Assignee: Medtronic, Inc.Inventors: Paul A. Belk, Jeffrey M. Gillberg, Jian Cao, Charles D. Swerdlow
-
Publication number: 20110054558Abstract: In general, the disclosure describes techniques for detecting lead related conditions, such as lead fractures or other lead integrity issues. As described herein, delivering an electrical signal through selected electrodes may result in, reveal, or amplify noise if a lead related condition is present. A processor may detect electrical noise indicative of the lead related condition subsequent to the delivery of the electrical signal, and identify a lead related condition in response to detecting the noise.Type: ApplicationFiled: March 8, 2010Publication date: March 3, 2011Applicant: Medtronic, Inc.Inventors: Bruce D. Gunderson, Kevin A. Wanasek, Charles D. Swerdlow
-
Publication number: 20100023072Abstract: Methods for determination of timing for electrical shocks to the heart to determine shock strength necessary to defibrillate a fibrillating heart. The timing corresponds the window of most vulnerability in the heart, which occurs during the T-wave of a heartbeat. Using a derivatized T-wave representation, the timing of most vulnerability is determined by a center of the area method, peak amplitude method, width method, or other similar methods. Devices are similarly disclosed embodying the methods of the present disclosure.Type: ApplicationFiled: July 24, 2008Publication date: January 28, 2010Inventors: Paul A. Belk, Jian Cao, Jeffrey M. Gillberg, Charles D. Swerdlow
-
Publication number: 20100023073Abstract: A method and apparatus sense a cardiac electrical signal and determine a signal quality parameter of the cardiac electrical signal. A number of shock pulses to be delivered to a patient's heart is determined in response to the signal quality parameter. Each of the shock pulses are scheduled to be delivered at a unique offset from a T-wave shock interval in one embodiment of the invention.Type: ApplicationFiled: July 24, 2008Publication date: January 28, 2010Inventors: Paul A. Belk, Charles D. Swerdlow, Linda L. Ruetz
-
Patent number: 7634316Abstract: A method and apparatus for validating a cardiac pacing pulse train preceding a T-shock. Validation of the pacing pulse train includes verifying capture of at least the last pacing pulse of the pulse train and verifying that intrinsic ventricular events are not sensed during a pacing train interval that includes at least the interval between the last pacing pulse and a scheduled T-shock delivery. Capture verification may include sensing an event during an ER sensing window, morphological analysis of a sensed event, and analysis of the temporal relationship between sensed events occurring on different EGM sources. The scheduled T-shock is delivered in response to a valid pacing pulse train. A response to an invalid pacing pulse train may include any of an invalid pacing train notification, withholding a scheduled T-shock, extension of the pacing train, repeating the pacing train, or adjusting the pacing pulse train parameters.Type: GrantFiled: April 28, 2005Date of Patent: December 15, 2009Assignees: Imperception, Inc., Medtronic, Inc.Inventors: Charles D. Swerdlow, William J. Havel
-
Publication number: 20090093860Abstract: A method and apparatus for determining a T-wave shock interval sense a cardiac electrogram (EGM) signal comprising a T-wave signal. A T-wave center is determined from the EGM signal, and a T-wave shock interval is determined in response to determining the T-wave center. A T-wave shock is delivered at the T-wave shock interval computed based on the T-wave center.Type: ApplicationFiled: October 3, 2007Publication date: April 9, 2009Inventors: Paul A. Belk, Jeffrey M. Gillberg, Jian Cao, Charles D. Swerdlow
-
Patent number: 7257441Abstract: A method for determining a cardiac shock strength, for example the programmed first-therapeutic shock strength of an implantable cardioverter defibrillator (ICD), including the steps of sensing a change in a T-wave of an electrogram with respect to time such as the maximum of the first derivative of a T-wave of an electrogram; delivering a test shock by (i) delivering a test shock at a test-shock strength and at a test-shock time relating to the maximum of the first derivative of the T-wave with respect to time; and (ii) sensing for cardiac fibrillation. If fibrillation is not sensed, test-shock delivery is repeated at the same test-shock strength and at specific, different test-shock times relating to the maximum of the first derivative of the T-wave. If fibrillation is still not sensed, the shock strength is decreased and test shocks are repeated at the same specific test shock times relative to the maximum of the first derivative of the T-wave.Type: GrantFiled: November 12, 2003Date of Patent: August 14, 2007Inventors: Charles D. Swerdlow, Kalyanam Shivkumar
-
Publication number: 20040106955Abstract: A method for determining a cardiac shock strength, for example the programmed first-therapeutic shock strength of an implantable cardioverter defibrillator (ICD), including the steps of sensing a change in a T-wave of an electrogram with respect to time such as the maximum of the first derivative of a T-wave of an electrogram; delivering a test shock by (i) delivering a test shock at a test-shock strength and at a test-shock time relating to the maximum of the first derivative of the T-wave with respect to time; and (ii) sensing for cardiac fibrillation. If fibrillation is not sensed, test-shock delivery is repeated at the same test-shock strength and at specific, different test-shock times relating to the maximum of the first derivative of the T-wave. If fibrillation is still not sensed, the shock strength is decreased and test shocks are repeated at the same specific test shock times relative to the maximum of the first derivative of the T-wave.Type: ApplicationFiled: November 12, 2003Publication date: June 3, 2004Inventors: Charles D. Swerdlow, Kalyanam Shivkumar
-
Patent number: 6711442Abstract: A method and apparatus that pretreat a patient prior to each therapeutic painful stimulus in a series of therapeutic painful stimuli, comprising the application of pain inhibiting stimuli to the patient prior to the application of each therapeutic painful stimulus in the series. Applying pain inhibiting stimuli comprises the steps of sensing a need for a next therapeutic painful stimulus in a series, preparing to deliver the pain inhibiting stimuli to the patient prior to applying the next therapeutic painful stimulus, and delivering the pain inhibiting stimuli to the patient prior to applying the next therapeutic painful stimulus. The method and apparatus are embodied in modern, noninvasive, transcutaneous or transesophageal pacing devices, either as stand-alone cardiac pacemakers, combination pacemaker-ECG monitors, or combination pacemaker-monitor-defibrillators. The pain inhibiting prepulse method is intended primarily for use in conscious patients but may also be used in sleeping patients.Type: GrantFiled: April 8, 1999Date of Patent: March 23, 2004Assignee: Imperception, IncorporatedInventors: Charles D. Swerdlow, Neal R. Swerdlow, James E. Brewer
-
Patent number: 6675042Abstract: A method for determining a cardiac shock strength, for example the programmed first-therapeutic shock strength of an implantable cardioverter defibrillator (ICD), including the steps of sensing a change in a T-wave of an electrogram with respect to time such as the maximum of the first derivative of a T-wave of an electrogram; delivering a test shock by (i) delivering a test shock at a test-shock strength and at a test-shock time relating to the maximum of the first derivative of the T-wave with respect to time; and (ii) sensing for cardiac fibrillation. If fibrillation is not sensed, test-shock delivery is repeated at the same test-shock strength and at specific, different test-shock times relating to the maximum of the first derivative of the T-wave. If fibrillation is still not sensed, the shock strength is decreased and test shocks are repeated at the same specific test shock times relative to the maximum of the first derivative of the T-wave.Type: GrantFiled: January 27, 2003Date of Patent: January 6, 2004Inventors: Charles D. Swerdlow, Kalyanam Shivkumar
-
Publication number: 20030195569Abstract: A method for determining a cardiac shock strength, for example the programmed first-therapeutic shock strength of an implantable cardioverter defibrillator (ICD), including the steps of sensing a change in a T-wave of an electrogram with respect to time such as the maximum of the first derivative of a T-wave of an electrogram; delivering a test shock by (i) delivering a test shock at a test-shock strength and at a test-shock time relating to the maximum of the first derivative of the T-wave with respect to time; and (ii) sensing for cardiac fibrillation. If fibrillation is not sensed, test-shock delivery is repeated at the same test-shock strength and at specific, different test-shock times relating to the maximum of the first derivative of the T-wave. If fibrillation is still not sensed, the shock strength is decreased and test shocks are repeated at the same specific test shock times relative to the maximum of the first derivative of the T-wave.Type: ApplicationFiled: January 27, 2003Publication date: October 16, 2003Inventors: Charles D. Swerdlow, Kalyanam Shivkumar
-
Patent number: 6438418Abstract: A method and apparatus for pretreating a patient prior to a therapeutic painful stimulus, comprising the application of pain inhibiting stimuli to a patient prior to an application of the therapeutic painful stimulus. Applying pain inhibiting stimuli comprises the steps of sensing a need for the therapeutic painful stimulus, preparing to deliver the pain inhibiting stimuli to the patient prior to applying the therapeutic painful stimulus, and delivering the pain inhibiting stimuli to the patient prior to applying the therapeutic painful stimulus. The method and apparatus are embodied in modern, fully automatic, fully implantable, single or dual chamber atrial or ventricular cardioverter-defibrillators. The pain inhibiting prepulse method is intended primarily for use in conscious patients but may also be used in sleeping patients.Type: GrantFiled: May 5, 2000Date of Patent: August 20, 2002Assignee: Imperception, IncorporatedInventors: Charles D. Swerdlow, Neal R. Swerdlow, James E. Brewer
-
Patent number: 6134479Abstract: An energy delivery system for use with an automatic external defibrillator (AED), the AED having a case containing a plurality of AED components, a battery electrically coupled to a control system, the control system communicatively coupled to a charge system, the charge system for generating a stored quantity of energy responsive to a communication from the control system, the control system selectively commanding a discharge of the stored energy to an electrical connector, the energy delivery system includes three electrodes, each electrode for making electrical contact with a skin surface of a patient, each electrode being in electrical contact with the electrical connector for communicating the stored energy to the patient.Type: GrantFiled: February 3, 1999Date of Patent: October 17, 2000Assignee: SurVivaLink CorporationInventors: James E. Brewer, Charles D. Swerdlow, Kenneth F. Olson
-
Patent number: 6091989Abstract: A method and apparatus for pretreating a patient prior to a therapeutic painful stimulus, comprising the application of pain inhibiting stimuli to a patient prior to an application of the therapeutic painful stimulus. Applying pain inhibiting stimuli comprises the steps of sensing a need for the therapeutic painful stimulus, preparing to deliver the pain inhibiting stimuli to the patient prior to applying the therapeutic painful stimulus, and delivering the pain inhibiting stimuli to the patient prior to applying the therapeutic painful stimulus. The method and apparatus are embodied in modem, fully automatic, fully implantable, single or dual chamber atrial or ventricular cardioverter-defibrillators. The pain inhibiting prepulse method is intended primarily for use in conscious patients but may also be used in sleeping patients.Type: GrantFiled: September 14, 1998Date of Patent: July 18, 2000Inventors: Charles D. Swerdlow, Neal R. Swerdlow, James E. Brewer